Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Preclinical Research

News in brief

NanoInk adds single cell array assay development services

09-Feb-2012

Related topics: Preclinical Research

NanoInk is offering contract development of live single cell array assays to improve toxicity testing and screening.

US-based NanoInk is using its DPN nanofabrication tools to build environments for attaching single cells. Using these environments biopharmaceutical companies can investigate cellular responses to biological or chemical stimuli.

 

Micropatterned single cells can also be harnessed to probe underlying mechanisms of cell behaviour like cell-cell interactions, cell-surface interactions, cell migration, and cell invasion”, Tom Warwick, general manager of the NanoFabrication Systems Division, said.

Follow us on